is retatrutide fda approved october 2025 Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation The FDA has issued warning
Description
Sore throat is not listed as a common direct side effect of Saxenda, though upper respiratory tract infections and nasopharyngitis are recognised adverse reactions
All healthcare decisions, including decisions about starting, stopping, or changing prescription medications, should be made in consultation with a qualified licensed healthcare provider

See GLP-1 fatigue guide for monitoring

Lastly, I can truly say that my results have been much better than my friends who have opted to go with other providers

Lajthia E, Bucheit JD, Nadpara PA, Dixon DL, Caldas LM, Murchie M, et al